|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/68 | |
| C07K 16/30 | |||
| A61K 31/4745 | |||
| A61K 31/708 | |||
| A61K 31/4375 | |||
| A61K 45/00 | |||
| A61P 35/00 |
| (11) | Number of the document | 3189082 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15839010.4 |
| Date of filing the European patent application | 2015-08-29 | |
| (97) | Date of publication of the European application | 2017-07-12 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2015/088456 |
| Date | 2015-08-29 |
| (87) | Number | WO 2016/034085 |
| Date | 2016-03-10 |
| (30) | Number | Date | Country code |
| 201410440824 | 2014-09-01 | CN |
| (72) |
LI, Lixin, CN
LAU, Walter, CN
|
| (73) |
Birdie Biopharmaceuticals Inc.,
Sertus Chambers P.O. Box 2547 Cassia Court Camana Bay, Grand Cayman,
KY
|
| (54) | ANTI-PD-L1 CONJUGATES FOR TREATING TUMORS |
| ANTI-PD-L1 CONJUGATES FOR TREATING TUMORS |